Literature DB >> 21566680

MAP Kinase Phosphatase-1 and Septic Shock.

Yusen Liu1, Thomas P Shanley.   

Abstract

Mitogen-activated protein (MAP)(§) kinase cascades are crucial signal transduction pathways in the biosynthesis of proinflammatory cytokines. MAP kinase phosphatase (MKP)-1, an archetypal member of the MKP family, plays a pivotal role in the feedback control of p38 and JNK. In vitro studies using cultured macrophages have provided strong evidence for a critical role of MKP-1 in the restraint of pro-inflammatory cytokine biosynthesis. Recently, a number of studies conducted using MKP-1 knockout mice have verified the importance of MKP-1 in the regulation of p38 and JNK and in the regulation of pro-inflammatory cytokine synthesis. Upon lipopolysaccharide challenge MKP-1 knockout mice produced dramatically greater amounts of inflammatory cytokines, developed severe hypotension, and multi-organ failure, and exhibited a remarkable increase in mortality. These studies demonstrate that MKP-1 is an essential feedback regulator of the innate immune response, and that it plays a critical role in preventing septic shock and multi-organ dysfunction during pathogenic infection.

Entities:  

Year:  2009        PMID: 21566680      PMCID: PMC3091010          DOI: 10.1080/17471060701200444

Source DB:  PubMed          Journal:  J Organ Dysfunct        ISSN: 1747-1060


  81 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 2.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

Review 3.  Molecular mechanisms of endotoxin tolerance.

Authors:  Hongkuan Fan; James A Cook
Journal:  J Endotoxin Res       Date:  2004

4.  The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts.

Authors:  D R Alessi; C Smythe; S M Keyse
Journal:  Oncogene       Date:  1993-07       Impact factor: 9.867

5.  Hemodynamic support in fluid-refractory pediatric septic shock.

Authors:  G Ceneviva; J A Paschall; F Maffei; J A Carcillo
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

6.  Dephosphorylation and inactivation of the mitogen-activated protein kinase by a mitogen-induced Thr/Tyr protein phosphatase.

Authors:  C F Zheng; K L Guan
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

7.  Detection and characterization by differential PCR of host eukaryotic cell genes differentially transcribed following uptake of intracellular bacteria.

Authors:  W R Schwan; S Kügler; S Schüller; D J Kopecko; W Goebel
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.

Authors:  Georg Stoecklin; Tiffany Stubbs; Nancy Kedersha; Stephen Wax; William F C Rigby; T Keith Blackwell; Paul Anderson
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

9.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

10.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Authors:  C Gérard; C Bruyns; A Marchant; D Abramowicz; P Vandenabeele; A Delvaux; W Fiers; M Goldman; T Velu
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  1 in total

1.  MAP kinase phosphatase-1, a critical negative regulator of the innate immune response.

Authors:  Liwu Li; Shuang-Feng Chen; Yusen Liu
Journal:  Int J Clin Exp Med       Date:  2009-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.